Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mycophenolate Mofetil for IgA Nephropathy Patients With Heavy Proteinuria Despite Angiotensin Blockade
NCT00863252Phase 4Completed
- Sponsor
- The University of Hong Kong
- Start
- Mar 2002
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mycophenolate mofetil in IgA nephropathy (IgAN), sponsored by The University of Hong Kong. Started Mar 2002; status: completed.
02
Drugs
mycophenolate mofetil
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on NCT00863252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00863252.